639 related articles for article (PubMed ID: 26875679)
41. Time To Let CRISPR B.E.?
Barrangou R
CRISPR J; 2019 Apr; 2():67. PubMed ID: 30998099
[No Abstract] [Full Text] [Related]
42. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
[TBL] [Abstract][Full Text] [Related]
43. Cas9 in close-up.
Garside EL; MacMillan AM
Nat Biotechnol; 2014 Apr; 32(4):338-40. PubMed ID: 24714483
[No Abstract] [Full Text] [Related]
44. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation.
Agne M; Blank I; Emhardt AJ; Gäbelein CG; Gawlas F; Gillich N; Gonschorek P; Juretschke TJ; Krämer SD; Louis N; Müller A; Rudorf A; Schäfer LM; Scheidmann MC; Schmunk LJ; Schwenk PM; Stammnitz MR; Warmer PM; Weber W; Fischer A; Kaufmann B; Wagner HJ; Radziwill G
ACS Synth Biol; 2014 Dec; 3(12):986-9. PubMed ID: 25524106
[TBL] [Abstract][Full Text] [Related]
45. Evolutionary dynamics of CRISPR gene drives.
Noble C; Olejarz J; Esvelt KM; Church GM; Nowak MA
Sci Adv; 2017 Apr; 3(4):e1601964. PubMed ID: 28435878
[TBL] [Abstract][Full Text] [Related]
46. CRISPR-Cas9 and CRISPR-Assisted Cytidine Deaminase Enable Precise and Efficient Genome Editing in Klebsiella pneumoniae.
Wang Y; Wang S; Chen W; Song L; Zhang Y; Shen Z; Yu F; Li M; Ji Q
Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217854
[No Abstract] [Full Text] [Related]
47. Current and future prospects for CRISPR-based tools in bacteria.
Luo ML; Leenay RT; Beisel CL
Biotechnol Bioeng; 2016 May; 113(5):930-43. PubMed ID: 26460902
[TBL] [Abstract][Full Text] [Related]
48. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease.
Gratz SJ; Cummings AM; Nguyen JN; Hamm DC; Donohue LK; Harrison MM; Wildonger J; O'Connor-Giles KM
Genetics; 2013 Aug; 194(4):1029-35. PubMed ID: 23709638
[TBL] [Abstract][Full Text] [Related]
49. The Genetic Basis of Reporter Mouse Strains.
Kim GN; Sung YH
Adv Exp Med Biol; 2021; 1310():551-564. PubMed ID: 33834450
[TBL] [Abstract][Full Text] [Related]
50. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
51. CRISPR technologies for bacterial systems: Current achievements and future directions.
Choi KR; Lee SY
Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
[TBL] [Abstract][Full Text] [Related]
52. Multiplexed CRISPR/Cas9- and TAR-Mediated Promoter Engineering of Natural Product Biosynthetic Gene Clusters in Yeast.
Kang HS; Charlop-Powers Z; Brady SF
ACS Synth Biol; 2016 Sep; 5(9):1002-10. PubMed ID: 27197732
[TBL] [Abstract][Full Text] [Related]
53. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
Amritha PP; Shah JM
Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
[TBL] [Abstract][Full Text] [Related]
54. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
55. BIOSAFETY. Safeguarding gene drive experiments in the laboratory.
Akbari OS; Bellen HJ; Bier E; Bullock SL; Burt A; Church GM; Cook KR; Duchek P; Edwards OR; Esvelt KM; Gantz VM; Golic KG; Gratz SJ; Harrison MM; Hayes KR; James AA; Kaufman TC; Knoblich J; Malik HS; Matthews KA; O'Connor-Giles KM; Parks AL; Perrimon N; Port F; Russell S; Ueda R; Wildonger J
Science; 2015 Aug; 349(6251):927-9. PubMed ID: 26229113
[No Abstract] [Full Text] [Related]
56. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
Zaidi SS; Mahfouz MM; Mansoor S
Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
[TBL] [Abstract][Full Text] [Related]
57. CRISPR-Cas system: a powerful tool for genome engineering.
Liu L; Fan XD
Plant Mol Biol; 2014 Jun; 85(3):209-18. PubMed ID: 24639266
[TBL] [Abstract][Full Text] [Related]
58. Engineering Synthetic Gene Circuits in Living Cells with CRISPR Technology.
Jusiak B; Cleto S; Perez-Piñera P; Lu TK
Trends Biotechnol; 2016 Jul; 34(7):535-547. PubMed ID: 26809780
[TBL] [Abstract][Full Text] [Related]
59. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.
Xu X; Qi LS
J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882
[TBL] [Abstract][Full Text] [Related]
60. Connecting genotypes, phenotypes and fitness: harnessing the power of CRISPR/Cas9 genome editing.
Bono JM; Olesnicky EC; Matzkin LM
Mol Ecol; 2015 Aug; 24(15):3810-22. PubMed ID: 26033315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
